The Asia Pacific 3D reconstruction market is estimated to project a CAGR of 8.17% during the forecast period, 2019-2028. It is assessed that there would be increased adoption of 3D reconstruction in the healthcare sector in the region, given its instrumental role in the treatment and diagnosis of diseases.
The Asia Pacific 3D reconstruction market growth assessment involves the evaluation of India, Japan, China, Australia & New Zealand, Indonesia, Vietnam, Thailand, South Korea, and the rest of Asia Pacific. Japan is a leader in Asia with regard to technological advancement and research. The country is making rapid progress in the 3D reconstruction industry, owing to increased demands for 3D technology. In 2018, the 3D reconstruction of plant structure was built by researchers at Osaka University, Japan. Moreover, Cyfuse Biomedical K.K. developed a viable 3D printer for producing accurate synthetic 3D printed human tissue. The company also partnered with the LifeNet Health Institute of Regenerative Medicine (IRM) to install a Regenova 3D bioprinter at the latter’s R&D center. Such initiatives are set to impact the growth of the market.
Some of the prominent companies progressing the market are Intel Corporation, Autodesk Inc, Vi3dim Technologies, Faro Technologies Inc, General Electric Company, etc.